EW vs MA · P/E 47, rev $1.39B vs P/E 38, rev $32.79B
Edwards Lifesciences Corp (EW) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
EW currently screens at market cap $49.91B and trailing P/E 46.9. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the EW and MA stock pages for the full models.
Not investment advice.